DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial.

Saved in:
Bibliographic Details
Title: DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial.
Authors: Yoshihara F; Division of Nephrology and Hypertension, National Cerebral and Cardiovascular Centre, Suita, Osaka, Japan., Imazu M; Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Centre, Suita, Osaka, Japan., Sakuma I; Division of Cardiology/Internal Medicine, Caress Sapporo Hokko Memorial Clinic, Sapporo, Japan., Hiroi Y; Department of Cardiology, National Centre for Global Health and Medicine, Tokyo, Japan., Hara H; Department of Cardiology, National Centre for Global Health and Medicine, Tokyo, Japan., Okazaki O; Cardiology, Okazaki Heart Clinic, Tokyo, Japan., Ishiguro C; Internal Medicine, Okazaki Heart Clinic, Tokyo, Japan., Izumi C; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Centre, Suita, Osaka, Japan., Noguchi T; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Centre, Suita, Osaka, Japan., Shiraiwa T; General Internal Medicine, Hypertension and Diabetes Centre, Shiraiwa Medical Clinic, Kashiwara, Japan., Nishioka N; General Internal Medicine, Cardiology and Cardiac Rehabilitation Centre, Shiraiwa Medical Clinic, Kashiwara, Japan., Fujii K; Division of Cardiology, Sakurabashi Watanabe Hospital, Osaka, Japan., Iwakura K; Division of Cardiology, Sakurabashi Watanabe Hospital, Osaka, Japan., Tomonaga O; Diabetes and Lifestyle Centre, Tomonaga Clinic, Tokyo, Japan., Kobayashi K; Department of Cardiology, TOYOTA Memorial Hospital, Toyota, Japan., Takihata M; Internal Medicine, Miura Central Clinic, Miura, Kanagawa, Japan., Yumoto K; Department of Cardiology, Yokohama Rosai Hospital, Yokohama, Kanagawa, Japan., Takase H; Department of Internal Medicine, JA Shizuoka Kohseiren Enshu Hospital, Hamamatsu, Shizuoka, Japan., Himi T; Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan., Shimizu I; Department of Diabetes, The Sakakibara Heart Institute of Okayama, Okayama, Japan., Murakami T; Department of Cardiology, Tokai University School of Medicine, Isehara, Kanagawa, Japan., Wagatsuma K; Tsukuba Heart Centre, Tsukuba Memorial Hospital, Tsukuba, Ibaragi, Japan., Sato K; Cardiovascular Medicine, Sapporo Cardio Vascular Clinic, Sapporo, Japan., Hiramatsu T; Department of Nephrology, Konan Kosei Hospital, Konan, Aichi, Japan., Akabame S; Department of Cardiovascular Medicine, Kyoto Okamoto Memorial Hospital, Kyoto, Japan., Hata S; Clinical Cardiology, Sasebo City General Hospital, Sasebo, Nagasaki, Japan., Asakura M; Department of Cardiovascular and Renal Medicine, Hyogo Medical University Hospital, Nishinomiya, Hyogo, Japan., Kawabata T; Department of Data Science, National Cerebral and Cardiovascular Centre, Suita, Osaka, Japan., Omae K; Department of Data Science, National Cerebral and Cardiovascular Centre, Suita, Osaka, Japan., Ito S; Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Centre, Suita, Osaka, Japan., Kitakaze M; Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Centre, Suita, Osaka, Japan.; Hanwa Memorial Hospital, Osaka, Japan.; The Osaka Medical Research Foundation for Intractable Diseases, Osaka, Japan.
Corporate Authors: DAPPER Investigators
Source: EClinicalMedicine [EClinicalMedicine] 2023 Nov 27; Vol. 66, pp. 102334. Date of Electronic Publication: 2023 Nov 27 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-5370
DOI:10.1016/j.eclinm.2023.102334